Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ERIBULIN MESYLATE INJECTION DIN 02564467

Status: Approved
Holder: MARCAN PHARMACEUTICALS INC
Molecule: ERIBULIN MESYLATE

Health Canada record

Active ingredient(s)ERIBULIN MESYLATE 0.5 MG
Dosage formSolution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCL01XX41 ERIBULIN
Original market date
Current status date09-Jan-2026
SourceHealth Canada DPD

Establishment licence of the holder

Marcan Pharmaceuticals Inc. — licence 101909, currently licensed, last inspection rating C (2024-05-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ERIBULIN MESYLATE

DINProductCompanyFormStrengthStatus
02545950ERIBULIN MESYLATE INJECTIONDR REDDY'S LABORATORIES LTDSolutionERIBULIN MESYLATE 0.5 MGMarketed
02560399ERIBULIN MESYLATE INJECTIONBAXTER CORPORATIONSolutionERIBULIN MESYLATE 0.5 MGApproved
02377438HALAVENEISAI LIMITEDSolutionERIBULIN MESYLATE 0.5 MGMarketed
02539136NAT-ERIBULINNATCO PHARMA (CANADA) INCSolutionERIBULIN MESYLATE 0.5 MGDormant

Notices of Compliance

NOCDateSubmissionReason
367122026-01-09Abbreviated New Drug Submission (ANDS)

International API supply for ERIBULIN MESYLATE

14 active FDA Drug Master Files.

Request a quote for ERIBULIN MESYLATE INJECTION

How to read a Canadian DIN record